Tech-Enabled Commercialization Is Pharmaceutical Manufacturing’s $400 Billion Missing Piece Pharma has embraced new strategies and tech for the R&D and manufacturing of products, but commercialization strategies and tech remain unchanged. While direct-to-consumer pharma spend has increased, the call to action for patients is inconvenient and unpersonalized: a static “talk to your doctor”